JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY20); Net Profit Down 24.0%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY20); Net Profit Down 24.0%
Sat, 1 Feb

JUBILANT LIFE SCIENCES has announced its results for the quarter ended December 2019. Here is a detailed performance review of the same:

JUBILANT LIFE SCIENCES Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-18*
3
Sep-19*
3
Dec-19*
QoQ ChangeYoY Change
Net SalesRs m23,77122,65923,1522.2%-2.6%
Other incomeRs m29012360-50.8%-79.2%
TurnoverRs m24,06122,78223,2121.9%-3.5%
ExpensesRs m18,83817,97518,0780.6%-4.0%
Gross profitRs m4,9334,6854,7280.9%-4.2%
DepreciationRs m9841,1681,135-2.9%15.3%
InterestRs m6837167200.5%5.5%
Profit before taxRs m3,5562,9222,9330.4%-17.5%
TaxRs m881428899109.9%2.1%
Profit after taxRs m2,6752,4942,034-18.4%-24.0%
Gross profit margin%20.820.720.4
Effective tax rate%24.814.730.7
Net profit margin%11.110.98.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 2.6% on a year-on-year (YoY) basis. The expenses were down by 4.0% YoY during the same period.
  • The company's operating profit declined by 4.2% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 20.4% in 3QFY20 as against 20.8% in 3QFY19.
  • Depreciation charges increased by 15.3% and finance costs increased by 5.5% YoY, respectively.
  • Other income declined by 79.2% YoY during the quarter.
  • Net profit for the quarter declined by 24.0% YoY. Net profit margins during the quarter declined from 11.1% in 3QFY19 to 8.8% in 3QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 2.2% on a quarter-on-quarter (QoQ) basis. The expenses were up by 0.6% QoQ during the same period.
  • The company's operating profit increased by 0.9% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 20.4% in 3QFY20 as against 20.7% in 2QFY19.
  • Net profit for the quarter declined by 18.4% QoQ, while net profit margins declined from 10.9% in 2QFY19 to 8.8% in 3QFY20.

To see how JUBILANT LIFE SCIENCES has performed over the last eight quarters,please visit here.

REVEALED: Brijesh Bhatia's Private Telegram Channel (JOIN NOW)

JUBILANT LIFE SCIENCES Share Price Performance

Over the last one year,JUBILANT LIFE SCIENCES share price has moved down from Rs 711.6 to Rs 570.6, registering a Loss of Rs 141.0 or around 19.8%.

Meanwhile, the S&P BSE OIL & GAS Index is trading at Rs 14,030.1 (up 0.8%). Over the last one year it has moved up from 13,633.8 to 14,030.1, a gain of 396 points (up 2.9%).

Overall, the S&P BSE SENSEX is up 12.6% over the year.

Current Valuations

At the current price of Rs 570.6, the price to earnings (P/E) ratio of JUBILANT LIFE SCIENCES stands at 16.9 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 1.9 times.

Equitymaster requests your view! Post a comment on "JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY20); Net Profit Down 24.0%". Click here!

  

Related Views on News

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY20); Net Profit Up 358.8% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 358.8% YoY). Sales on the other hand came in at Rs 24 bn (up 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (2QFY20); Net Profit Up 18.9% (Quarterly Result Update)

Oct 31, 2019 | Updated on Oct 31, 2019

For the quarter ended September 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 18.9% YoY). Sales on the other hand came in at Rs 23 bn (down 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

More Views on News

Most Popular

RBI Opens a New Market for Investors(Fast Profits Daily)

Jul 16, 2021

You now have a new way to create wealth. Grab it with both hands.

These Are the Best Stocks to Own(Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

India's Vulture Moment Against China(Fast Profits Daily)

Jul 15, 2021

India has a great opportunity to grab market share from China. Profit from it.

Top 5 Stocks Mutual Funds Bought and Sold in June 2021(Views On News)

Jul 15, 2021

A look at what India's top equity mutual funds bought and sold in June 2021.

Zomato: Worth a Bite?(Profit Hunter)

Jul 15, 2021

Zomato has been a consumer's delight. Can it be an investor's delight too?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT PHARMOVA SHARE PRICE


Jul 28, 2021 (Close)

TRACK JUBILANT PHARMOVA

  • Track your investment in JUBILANT PHARMOVA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT PHARMOVA

JUBILANT PHARMOVA - JUBILANT INGREVIA COMPARISON

COMPARE JUBILANT PHARMOVA WITH

MARKET STATS